Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 362

recruiting
3 967
countries
28
conditions
2 124

10 514 trials match your criteria

Hepatic cirrhosis+1

Not yet recruiting

Study of Tinzaparin Sodium to Prevent Venous Thromboembolism in Adults with Liver Cirrhosis and Hepatocellular Carcinoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Tinzaparin Sodium

Major depression

Not yet recruiting

Effect of Prucalopride Added to Sertraline Compared with Placebo on Mood and Memory in Women with Major Depressive Disorder

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Placebo

Choroid melanoma

Not yet recruiting

Long‑Term Follow‑Up Study of Belzupacap Sarotalocan in Patients with Early Choroidal Melanoma

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Belzupacap Sarotalocan

Hodgkin's disease

Not yet recruiting

Phase II Study of Brentuximab Vedotin with Drug Combination in HIV‑Positive Patients with Advanced‑Stage Classic Hodgkin Lymphoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Brentuximab Vedotin

Non-small cell lung cancer

Not yet recruiting

Phase II Randomized Trial of Adjuvant Durvalumab Immunotherapy After Neoadjuvant Chemoimmunotherapy in Patients With Resectable Non‑Small Cell Lung Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab

Varicella+5

Not yet recruiting

Immune response and safety of investigational MMRV vaccine (GSKVX000000025896) drug combination compared with standard MMRV vaccine in healthy children 15 months to 6 years

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000025896

Coronary artery disease

Not yet recruiting

Continuing vs Stopping Acetylsalicylic Acid in Elderly Patients with Chronic Coronary Syndrome (Secondary Prevention): A Randomized Trial

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:65+ years
  • Substances:Acetylsalicylic Acid

End stage renal disease+1

Not yet recruiting

Safety and efficacy of locally administered APAC, heparin sodium and sodium chloride to promote arteriovenous fistula maturation in patients with end‑stage kidney disease

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Heparin Sodium

B-cell type acute leukaemia

Not yet recruiting

Phase II study of inotuzumab ozogamicin to prevent relapse in adult high‑risk acute lymphoblastic leukaemia patients after allogeneic stem cell transplant

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Inotuzumab Ozogamicin

Effect of Methylphenidate versus Placebo on Attachment‑Related Learning in Children with Attention‑Deficit/Hyperactivity Disorder (ADHD)

Registered drug
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Methylphenidate Hydrochloride

Depression

Not yet recruiting

Effect of methohexital, propofol, and etomidate on electroconvulsive therapy outcomes in patients with severe depression

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Etomidate

Breast cancer

Not yet recruiting

Study of ribociclib with drug combination in early breast cancer patients to test de‑escalated treatment strategies

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.